Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 274 and 501 of Human Nicotinic Acetylcholine Receptor beta|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-29991 targets Nicotinic Acetylcholine Receptor beta in IHC (P) and WB applications and shows reactivity with Human samples.
The PA5-29991 immunogen is recombinant fragment corresponding to a region within amino acids 274 and 501 of Human Nicotinic Acetylcholine Receptor beta.
The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
acetylcholine receptor; acetylcholine receptor subunit beta; acetylcholine receptor, nicotinic, beta 1 (muscle); ACHRB; beta 1 (muscle); beta polypeptide 1 (muscle); cholinergic receptor; cholinergic receptor, nicotinic beta 1; cholinergic receptor, nicotinic, beta 1 (muscle); cholinergic receptor, nicotinic, beta polypeptide 1 (muscle); CHRNB; CMS1D; CMS2A; nicotinic; SCCMS
ACHRB; CHRNB; CHRNB1; CMS1D; CMS2A; CMS2C; SCCMS